CAN NOVEL AGENTS OVERCOME THE NEGATIVE PROGNOSTIC IMPACT OF RENAL IMPAIRMENT IN MULTIPLE MYELOMA? - A POPULATION BASED STUDY INCLUDING 1538 PATIENTS

被引:0
|
作者
Uttervall, K. [1 ]
Lund, J. [1 ]
Liwing, J. [1 ]
Holmberg, E. [2 ]
Alici, E. [1 ]
Aschan, J. [3 ]
Nahi, H. [1 ]
机构
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
[2] Univ Gothenburg, Dept Oncol, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden
[3] Janssen Cilag AB, Sollentuna, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P781
引用
收藏
页码:326 / 327
页数:2
相关论文
共 50 条
  • [21] The Role of Novel Agents on Reversibility of Renal Impairment in Newly Diagnosed Patients with Multiple Myeloma; a Single Center Experience on 112 Patients
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gkotzamanidou, Maria
    Psimenou, Erasmia
    Mparmparoussi, Despoina
    Matsouka, Charis
    Terpos, Evangelos
    Kastritis, Efstathios
    BLOOD, 2011, 118 (21) : 1694 - 1694
  • [22] Impact of Renal Impairment Criteria on Survival of Patients With Newly Diagnosed Multiple Myeloma
    Strufaldi, Fernando L.
    Segura, Gabriela C.
    Caires, Renato A.
    Mattedi, Francisco Z.
    Costalonga, Elerson
    Martinez, Gracia
    Costa e Silva, Veronica T.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 643 - 643
  • [23] Novel agents have a significant impact on survival of patients with multiple myeloma
    Lamm, Wolfgang
    Eder, Sandra
    Bojic, Marija
    Zielinski, Christoph C.
    Drach, Johannes
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (3-4) : 92 - 97
  • [24] Novel agents have a significant impact on survival of patients with multiple myeloma
    Lamm, W.
    Eder, S.
    Gruber, M.
    Zielinski, C.
    Drach, J.
    ONKOLOGIE, 2011, 34 : 155 - 155
  • [25] The Addition of IMiDs for Patients with Daratumumab-Refractory Multiple Myeloma Can Overcome Refractoriness to Both Agents
    Fotiou, Despina
    Gavriatopoulou, Maria
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Kanellias, Nikolaos
    Malandrakis, Panagiotis
    Theodorakakou, Foteini
    Dialoupi, Ioanna
    Eleutherakis-Papaiakovou, Evangelos
    Roussou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    BLOOD, 2020, 136
  • [26] Impact of Dialysis Dependence on Survival for Multiple Myeloma Patients with Renal Impairment: A Multicenter Retrospective Study in China
    Jian, Yuan
    Zhou, Huixing
    Xie, Weiwei
    Ren, Yuan
    Zhang, Zhiyao
    Yang, Guangzhong
    Geng, Chuanying
    Jia, Jing
    Chen, Wenming
    Li, Jian
    Huang, Wenrong
    Cen, Xinan
    Gao, Wen
    BLOOD, 2022, 140 : 12635 - 12636
  • [27] The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents
    Gavriatopoulou, Maria
    Kastritis, Efstathios
    Ntanasis-Stathopoulos, Ioannis
    Fotiou, Despina
    Roussou, Maria
    Migkou, Magdalini
    Ziogas, Dimitrios C.
    Kanellias, Nikolaos
    Terpos, Evangelos
    Dimopoulos, Meletios Athanasios
    BLOOD, 2018, 131 (04) : 464 - 467
  • [28] Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
    Lee, Sung-Eun
    Jeon, Young-Woo
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong Wook
    Min, Woo-Sung
    Min, Chang-Ki
    BLOOD RESEARCH, 2018, 53 (02) : 123 - 129
  • [29] Renal Impairment Is Not An Independent Adverse Prognostic Factor In Multiple Myeloma Patients Who Are Treated Upfront with Novel Agent-Based Regimens.
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    Roussou, Maria
    Gavriatopoulou, Maria
    Migkou, Magdalini
    Gkotzamanidou, Maria
    Iakovaki, Marina
    Matsouka, Charis
    Mparmparousi, Despina
    Nikitas, Nikitas
    Gika, Dimitra
    Grapsa, Irene
    Psimenou, Erasmia
    Terpos, Evangelos
    BLOOD, 2010, 116 (21) : 1250 - 1251
  • [30] Prognostic impact of renal failure recovery in patients with newly diagnosed multiple myeloma
    Pena, Camila
    Valladares, Ximena
    Gajardo, Claudia
    Russo, Moises
    Morales, Alvaro
    Correa, Gonzalo
    Valjalo, Ricardo
    REVISTA MEDICA DE CHILE, 2019, 147 (11) : 1374 - 1381